More delays? Now Roche’s CEO says he’s willing to wait well into next year to complete their $4.3B Spark buyout
Roche CEO Severin Schwan wants the staff at Spark to know that he’s absolutely committed to completing his $4.3 billion deal to buy the gene therapy company. And he’s prepared to wait well into 2020 to get it, if necessary.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 73,300+ biopharma pros reading Endpoints daily — and it's free.